<DOC>
	<DOCNO>NCT00484731</DOCNO>
	<brief_summary>The effect intraoperative infiltration operation site bupivacain development chronic pain object trial . We hypothesize occurrence chronic pain goup patient receive infiltration 50 % less placebo group receive normal saline . The study randomize control triple blind trial sequential study design .</brief_summary>
	<brief_title>Effect Intraoperative Infiltration With Bupivacain Development Chronic Pain After Inguinal Hernia Repair</brief_title>
	<detailed_description>264 patient schedule inguinal hernia repair use one three procedure ( Lichtenstein , Barwell TEP = total extraperitoneal hernioplasty ) randomly allocate intra-operatively two group . Group I patient receive local injection 20ml Carbostesin® 0.25 % end operation accord standardised procedure . Group II patient get 20 ml placebo ( 0.9 % Saline ) injection . We use pre-filled identically look syrinx blind injection , i.e . patient , surgeon examinator performs postoperative clinical follow-up remain unaware group allocation . The primary outcome study occurrence develop chronic pain ( define persistent pain 3 month FU ) measure VAS Pain Matcher® device ( Cefar Medical AB , Lund , Sweden ) . In addition sample size re-evaluation three interim analysis plan 120 , 180 240 patient finish 3-months follow-up allow early study termination .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Hernia , Inguinal</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Adult patient ( ≥ 18 year ) primary recurrent single double side symptomatic incarcerated inguinal hernia elective hernia repair include . No intervention ( i.e . umbilical hernia ) allow . Written informed consent need obtain . Patients legal incompetence , Pregnant nursing woman , Patients presence history active malignancy systemic disease , Under immunosuppressive treatment , With systemic severe local inflammation infection , With wound heal disorder physical mental incapacity , make impossible obtain informed consent exclude . As pacemaker interfere electrical stimulation Pain Matcher® vice versa patient pacemaker implant electrical device also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>